1. Sun, Ting, Tong, Wenxian, Pu, Jie, Yu, Zhiguo, Kang, Zhengchun. 2023. SH3BP1 Regulates Melanoma Progression Through Race1/Wace2 Signaling Pathway. In Clinical Medicine Insights. Oncology, 17, 11795549231168075. doi:10.1177/11795549231168075. https://pubmed.ncbi.nlm.nih.gov/37114076/
2. Wang, Jingjing, Feng, Yeqian, Chen, Xishan, Ma, Shuyun, Zou, Wen. 2017. SH3BP1-induced Rac-Wave2 pathway activation regulates cervical cancer cell migration, invasion, and chemoresistance to cisplatin. In Journal of cellular biochemistry, 119, 1733-1745. doi:10.1002/jcb.26334. https://pubmed.ncbi.nlm.nih.gov/28786507/
3. Parrini, Maria Carla, Sadou-Dubourgnoux, Amel, Aoki, Kazuhiro, Rossé, Carine, Camonis, Jacques. . SH3BP1, an exocyst-associated RhoGAP, inactivates Rac1 at the front to drive cell motility. In Molecular cell, 42, 650-61. doi:10.1016/j.molcel.2011.03.032. https://pubmed.ncbi.nlm.nih.gov/21658605/
4. Yang, Li, Xu, Qiang, Li, Junnan. 2024. Prognostic impact of ARHGAP43(SH3BP1) in acute myeloid leukemia. In Journal of the Formosan Medical Association = Taiwan yi zhi, 123, 992-1003. doi:10.1016/j.jfma.2024.04.002. https://pubmed.ncbi.nlm.nih.gov/38582737/
5. Tata, Aleksandra, Stoppel, David C, Hong, Shangyu, Xie, Tiao, Gu, Chenghua. 2014. An image-based RNAi screen identifies SH3BP1 as a key effector of Semaphorin 3E-PlexinD1 signaling. In The Journal of cell biology, 205, 573-90. doi:10.1083/jcb.201309004. https://pubmed.ncbi.nlm.nih.gov/24841563/
智鼠故事 
